Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Teen injury prevention gets personal: new study matches exercise to growth

NCT ID NCT07385794

Prevention Sponsor: University of Alicante Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a personalized exercise program for 120 teens aged 14-15 to prevent injuries. Instead of using age alone, the program is tailored to each teen's biological growth stage. Participants get a 12-week plan to improve strength, balance, and mobility, aiming to reduce injury risk in sports and daily life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 15 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents aged 14 to 15 years at the time of enrollment. * Male and female participants. * Apparently healthy adolescents without diagnosed chronic medical conditions. * Participation in regular school physical education and/or organized sports activities. * Ability to participate in moderate physical activity as determined by a pre-participation screening. * Written informed consent obtained from parents or legal guardians, and assent from the participant. Exclusion Criteria: * Presence of acute or chronic musculoskeletal injury that limits participation in physical activity at the time of enrollment. * History of musculoskeletal surgery within the previous 12 months. * Diagnosed neurological, cardiovascular, metabolic, or systemic disease that contraindicates physical exercise. * Current participation in another structured exercise or intervention study. * Use of medication that may significantly affect musculoskeletal function or physical performance. * Any condition that, in the opinion of the investigators, could compromise participant safety or adherence to the protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent growth and development are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent growth and development Injury prevention Musculoskeletal health

Contacts and locations

Locations

  • European Institute of Exercise and Health

    Alicante, Elche, 03202, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.